XAIR – Beyond Air Inc
XAIR
$0.3503Name : Beyond Air, Inc.
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $30,923,994.00
EPSttm : -1
Beyond Air, Inc.
$0.3503
Float Short %
1.13
Margin Of Safety %
Put/Call OI Ratio
0.01
EPS Next Q Diff
0.15
EPS Last/This Y
EPS This/Next Y
Price
0.35
Target Price
2.25
Analyst Recom
1.4
Performance Q
-31.15
Relative Volume
0.58
Beta
0.12
Ticker: XAIR
21 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-01-23 | XAIR | 0.4172 | 0.00 | 0.01 | 5035 |
2025-01-24 | XAIR | 0.4273 | 0.00 | 0.00 | 5084 |
2025-01-27 | XAIR | 0.4052 | 0.00 | 0.00 | 5274 |
2025-01-28 | XAIR | 0.3829 | 0.00 | 0.00 | 5579 |
2025-01-29 | XAIR | 0.388 | 0.00 | 0.00 | 5621 |
2025-01-30 | XAIR | 0.3837 | 0.00 | 0.04 | 5629 |
2025-01-31 | XAIR | 0.3913 | 0.00 | 0.04 | 5654 |
2025-02-03 | XAIR | 0.3609 | 0.00 | 0.00 | 5744 |
2025-02-04 | XAIR | 0.392 | 0.00 | 0.03 | 5782 |
2025-02-05 | XAIR | 0.4083 | 0.00 | 0.03 | 5924 |
2025-02-06 | XAIR | 0.4007 | 0.00 | 0.00 | 6180 |
2025-02-07 | XAIR | 0.422 | 0.00 | 0.01 | 6503 |
2025-02-10 | XAIR | 0.4301 | 0.00 | 0.01 | 7070 |
2025-02-11 | XAIR | 0.4142 | 0.02 | 0.01 | 9173 |
2025-02-12 | XAIR | 0.376 | 0.02 | 0.11 | 9646 |
2025-02-13 | XAIR | 0.3714 | 0.02 | 0.32 | 9660 |
2025-02-14 | XAIR | 0.384 | 0.02 | 0.01 | 9685 |
2025-02-18 | XAIR | 0.363 | 0.02 | 0.00 | 9914 |
2025-02-19 | XAIR | 0.377 | 0.02 | 1.55 | 9971 |
2025-02-20 | XAIR | 0.3599 | 0.02 | 0.03 | 9974 |
2025-02-21 | XAIR | 0.3565 | 0.01 | 0.03 | 9877 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-01-23 | XAIR | 0.42 | - | - | 0.00 |
2025-01-24 | XAIR | 0.43 | - | - | 0.00 |
2025-01-27 | XAIR | 0.40 | - | - | 0.00 |
2025-01-28 | XAIR | 0.39 | - | - | 0.00 |
2025-01-29 | XAIR | 0.39 | - | - | 0.00 |
2025-01-30 | XAIR | 0.38 | - | - | 0.00 |
2025-01-31 | XAIR | 0.39 | - | - | 0.00 |
2025-02-03 | XAIR | 0.36 | - | - | 0.00 |
2025-02-04 | XAIR | 0.39 | - | - | 0.00 |
2025-02-05 | XAIR | 0.41 | - | - | 0.00 |
2025-02-06 | XAIR | 0.40 | - | - | 0.00 |
2025-02-07 | XAIR | 0.42 | - | - | 0.00 |
2025-02-10 | XAIR | 0.44 | - | - | 0.00 |
2025-02-11 | XAIR | 0.41 | - | - | 0.00 |
2025-02-12 | XAIR | 0.37 | - | - | 0.00 |
2025-02-13 | XAIR | 0.37 | - | - | 0.00 |
2025-02-14 | XAIR | 0.39 | - | - | 0.00 |
2025-02-18 | XAIR | 0.36 | - | - | 0.00 |
2025-02-19 | XAIR | 0.38 | - | - | 0.00 |
2025-02-20 | XAIR | 0.36 | - | - | 0.00 |
2025-02-21 | XAIR | 0.35 | - | - | 0.00 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-01-23 | XAIR | 45.66 | 154.91 | 1.87 |
2025-01-24 | XAIR | 45.66 | 154.91 | 1.87 |
2025-01-27 | XAIR | 45.66 | 154.91 | 1.87 |
2025-01-28 | XAIR | 45.66 | 154.91 | 1.56 |
2025-01-29 | XAIR | 45.65 | 154.91 | 1.56 |
2025-01-30 | XAIR | 45.66 | 154.91 | 1.56 |
2025-01-31 | XAIR | 45.65 | 154.91 | 1.56 |
2025-02-03 | XAIR | 45.66 | 165.11 | 1.56 |
2025-02-04 | XAIR | 42.37 | 165.11 | 1.56 |
2025-02-05 | XAIR | 42.37 | 165.11 | 1.48 |
2025-02-06 | XAIR | 42.38 | 165.11 | 1.48 |
2025-02-07 | XAIR | 42.38 | 165.11 | 1.48 |
2025-02-10 | XAIR | 42.38 | 39.26 | 1.48 |
2025-02-11 | XAIR | 42.38 | 39.26 | 1.48 |
2025-02-12 | XAIR | 42.37 | 39.26 | 1.31 |
2025-02-13 | XAIR | 34.47 | 39.26 | 1.13 |
2025-02-14 | XAIR | 34.46 | 39.26 | 1.13 |
2025-02-18 | XAIR | 31.13 | 38.46 | 1.13 |
2025-02-19 | XAIR | 31.13 | 38.46 | 1.13 |
2025-02-20 | XAIR | 30.45 | 38.46 | 1.13 |
2025-02-21 | XAIR | 30.46 | 38.46 | 1.13 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
21 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.15
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
30.46
Institutional Transactions
38.46
Beta
0.12
Average Sales Estimate Current Quarter
1
Average Sales Estimate Next Quarter
2
Fair Value
Quality Score
22
Growth Score
45
Sentiment Score
20
Actual DrawDown %
97.9
Max Drawdown 5-Year %
-98.1
Target Price
2.25
P/E
Forward P/E
PEG
P/S
10.24
P/B
1.48
P/Free Cash Flow
EPS
-1.05
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-1730
Relative Volume
0.58
Return on Equity vs Sector %
-315.7
Return on Equity vs Industry %
-308.5
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Sector: Healthcare
Industry: Medical Devices
Employees: 107
Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through two segments, Beyond Air and Beyond Cancer. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. In addition, the company develops ultra-high concentration NO in Phase 1 clinical trial to treat solid tumors. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.
stock quote shares XAIR – Beyond Air Inc Stock Price stock today
news today XAIR – Beyond Air Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch XAIR – Beyond Air Inc yahoo finance google finance
stock history XAIR – Beyond Air Inc invest stock market
stock prices XAIR premarket after hours
ticker XAIR fair value insiders trading